Connective tissue growth factor (CCN2) in blood vessels

Vascular Pharmacology

Volumn 58, Issue 3, 2013, Pages 189-193

  Ponticos, Markella ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; CCN family; CTGF; Vascular pathology

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; GROWTH FACTOR; HEPARIN; INTEGRIN; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PROTEIN CCN4; PROTEIN CCN5; PROTEIN CCN6; PROTEOGLYCAN; SOMATOMEDIN BINDING PROTEIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADIPOCYTE; ANGIOGENESIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL PROLIFERATION; EARLY RESPONSE GENE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MOLECULAR RECOGNITION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PROTEIN INTERACTION; WOUND HEALING;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; CONNECTIVE TISSUE GROWTH FACTOR; HUMANS; VASCULAR DISEASES;

EID: 84875367781     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.01.004     Document Type: Article

References (68)

1. Abreu J.G., et al. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 2002, 4(8):599-604. (Aug).
2. Ahmed M.S., et al. Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J. Mol. Cell. Cardiol. 2004, 36(3):393-404. (Mar).
3. Ahmed M.S., et al. Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling. Cardiovasc. Res. 2007, 74(2):323-333. (May 1).
4. 3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. 1999, 19:2958-2966.
5. Baguma-Nibasheka M., Kablar B. Pulmonary hypoplasia in the connective tissue growth factor (CTGF) null mouse. Dev. Dyn. 2008, 237(2):485-493. (Feb).
6. Bornstein P., Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 2002, 14(5):608-616. (Oct).
7. Bou-Gharios G., et al. Extra-cellular matrix in vascular networks. Cell Prolif. 2004, 37(3):207-220. (June).
8. Chaqour B., Goppelt-Struebe M. Mechanical regulation of the Cyr61/CCN1 and CTGF proteins. FEBS J. 2006, 273(16):3639-3649. (Aug).
9. Chen C.C., Lau L.F. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 2009, 41(4):771-783. (Apr).
10. Chen M.M., et al. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J. Mol. Cell. Cardiol. 2000, 32(10):1805-1819. (Oct).
11. Chen Y., et al. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol. Biol. Cell 2004, 15(12):5635-5646. (Dec).
12. Chuva de Sousa Lopes S.M., et al. Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Dev. Dyn. 2004, 231(3):542-550. (Nov).
13. Cicha I., Goppelt-Struebe M. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors 2009, 35(2):200-208. (Mar-Apr).
14. Cicha I., et al. Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler. Thromb. Vasc. Biol. 2005, 25(5):1008-1013. (May).
15. Geary R.L., et al. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 2002, 22(12):2010-2016. (Dec 1).
16. Gössl M., et al. Inhibition of vasa vasorum neovascularization prevents vessel wall inflammation and intimal hyperplasia in early atherosclerosis. Circulation 2006, 31114(18 Suppl.):186. (Oct., Abstract).
17. Gössl M., et al. Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location-determination of atherogenesis. Atherosclerosis 2009, 206(2):362-368. (Oct).
18. Grote K., Gössl M., et al. The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration. Blood 2007, 110(3):877-885. (Aug 1).
19. Grotendorst G.R., Okochi H., Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 1996, 7(4):469-480. (Apr).
20. Hall-Glenn F., Lyons K.M. Roles for CCN2 in normal physiological processes. Cell. Mol. Life Sci. 2011, 68:3209-3217.
21. Hashimoto G., Hashimoto G., et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor. J. Biol. Chem. 2002, 277(39):36288-36295. (Sep 27).
22. Hayata N., et al. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem. Biophys. Res. Commun. 2008, 370(2):274-278. (May 30).
23. He Z., et al. Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J. Biol. Chem. 2005, 280(16):15719-15726. (2005 Apr 22).
24. Hishikawa K., et al. Over expression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999, 100(20):2108-2112. (Nov 16).
25. Holbourn K.P., Acharya K.R., Perbal B. The CCN family of proteins: structure-function relationships. Trends Biochem. Sci. 2008, 33(10):461-473. (October).
26. Holmes A., Gössl M., et al. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem. 2001, 276(14):10594-10601. (Apr 6).
27. Inoki I., et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 2002, 16(2):219-221. (Feb).
28. Ivkovic S., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003, 130(12):2779-2791. (Jun).
29. Jedsadayanmata A., et al. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J. Biol. Chem. 1999, 274(34):24321-24327. (Aug 20).
30. Kanazawa S., et al. The expression of platelet-derived growth factor and connective tissue growth factor in different types of abdominal aortic aneurysms. J. Cardiovasc. Surg. (Torino) 2005, 46(3):271-278. (Jun).
31. Kennedy L., et al. CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp. Cell Res. 2007, 313(5):952-964. (Mar 10).
32. Kondo S., et al. Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF) by vascular endothelial growth factor in human endothelial cells. Mol. Cancer Ther. 2006, 5(1):129-137. (Jan).
33. Kubota S., et al. Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: similarities to retroviral RNA-protein interactions. Oncogene 2000, 19(41):4773-4786. (Sep 28).
34. Kuiper E.J., et al. Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J. Histochem. Cytochem. 2007, 55(11):1139-1147. (Nov).
35. Kundi R., et al. Arterial gene transfer of the TGF-{beta} signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc. Res. 2009, 84(2):326-335. (Nov 1).
36. -/- double knockout mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26:347-352.
37. Langheinrich A.C., et al. 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE(-/-)/LDL(-/-) double knockout mice. Atherosclerosis 2009, 202(1):103-110. (Jan, Epub 2008 Apr 16).
38. Leask A., Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J. 2004, 18(7):816-827. (May).
39. Leask A., Abraham D.J. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 2006, 119(Pt 23):4803-4810. (Dec 1).
40. Leask A., et al. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J. Biol. Chem. 2003, 278(15):13008-13015. (Apr 11).
41. Libby P. Atherosclerosis: disease biology affecting the coronary vasculature. Am. J. Cardiol. 2006, 98(12A):3Q-9Q. (Dec 18).
42. Libby P. Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis. J. Lipid Res. 2009, 50:S352-S357.
43. Mason R.M. Connective tissue growth factor (CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?. J. Cell Commun. Signal. 2009, 3(2):95-104.
44. Moulton K.S., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4736-4741.
45. Moussad E.E., Brigstock D.R. Connective tissue growth factor: what's in a name?. Mol. Genet. Metab. 2000, 71(1-2):276-292. (Sep-Oct).
46. Newby A.C. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol. 2008, 28(12):2108-2114. (December).
47. Oemar B.S., Lüscher T.F. Connective tissue growth factor. Friend or foe?. Arterioscler. Thromb. Vasc. Biol. 1997, 17(8):1483-1489.
48. Oemar B.S., et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997, 95(4):831-839. (18).
49. Ohnishi H., et al. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J. Mol. Cell. Cardiol. 1998, 30(11):2411-2422.
50. Ponticos M., et al. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. 2009, 60(7):2142-2155.
51. Recchia A.G., et al. Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes. J. Mol. Cell. Cardiol. 2009, 46(3):352-359.
52. Rekhter M.D. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc. Res. 1999, 41(2):376-384.
53. Rekhter M.D. How to evaluate plaque vulnerability in animal models of atherosclerosis?. Cardiovasc. Res. 2002, 54(1):36-41. (April).
54. Rodriguez-Vita J., et al. Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells. Circ. Res. 2005, 97(2):125-134. (22).
55. Rupérez M., et al. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 2003, 108(12):1499-1505. (Sep 23).
56. Rupérez M., et al. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Hypertension 2007, 50(2):377-383. (Aug).
57. Schober J.M., et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 2002, 99(12):4457-4465. (Jun 15).
58. Shi Y., Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113(6):685-700. (Jun 13).
59. Shi-wen X., et al. CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J. Biol. Chem. 2006, 281(16):10715-10726. (Apr 21).
60. Shi-Wen X., et al. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008, 19(2):133-144. (Apr).
61. Shi-wen X., Parapuram S.K., Pala D., Chen Y., Carte D.E., Eastwood M., Denton C.P., Abraham D.J., Leask A. Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts. Arthritis Rheum. 2009, 60(1):234-241. (Jan). 10.1002/art.24223.
62. Suzuma K., et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J. Biol. Chem. 2000, 275(52):40725-40731. (Dec 29).
63. Tan J.T., et al. Connective tissue growth factor inhibits adipocyte differentiation. Am. J. Cell Physiol. 2008, C740-C751.
64. Velasco S. L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J. Cell Sci. 2008, 121(Pt 6):913-919. (Mar 15).
65. Virmani R., et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2000, 20(5):1262-1275. (May).
66. Wang X., et al. Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 2006, 114(1 Suppl.):I200-I205. (Jul 4).
67. Wang X.Y., et al. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor. Am. J. Physiol. Cell Physiol. 2009, 297(6):C1490-C1500. (Dec).
68. Weber C., et al. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 2008, 8(10):802-815. (October).